Bessemer Group
GMAB icon

Bessemer Group’s Genmab GMAB Stock Holding History

Bessemer Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
526
+7
+1% +$186 ﹤0.01% 2069
2026
Q1 		$13K Sell
519
-265
-34% -$7.94K ﹤0.01% 2041
2025
Q4 		$23K Buy
784
+498
+174% +$15.5K ﹤0.01% 1845
2025
Q3 		$8K Buy
286
+55
+24% +$1.34K ﹤0.01% 2017
2025
Q2 		$5K Hold
231
– – ﹤0.01% 2022
2025
Q1 		$5K Buy
231
+105
+83% +$2.2K ﹤0.01% 2010
2024
Q4 		$3K Hold
126
– – ﹤0.01% 2123
2024
Q3 		$3K Buy
+126
New +$3.37K ﹤0.01% 2091
2024
Q2 		– Sell
-185
Closed -$6K – 2077
2024
Q1 		$6K Buy
+185
New +$5.43K ﹤0.01% 1667
2023
Q3 		– Sell
-250
Closed -$10K – 2217
2023
Q2 		$10K Sell
250
-19
-7% -$758 ﹤0.01% 1648
2023
Q1 		$10K Buy
269
+214
+389% +$8.23K ﹤0.01% 1476
2022
Q4 		$2K Sell
55
-159
-74% -$6.55K ﹤0.01% 1768
2022
Q3 		$7K Buy
+214
New +$7.51K ﹤0.01% 1624
2022
Q2 		– Sell
-683
Closed -$25K – 1928
2022
Q1 		$25K Sell
683
-473
-41% -$16.2K ﹤0.01% 1206
2021
Q4 		$46K Buy
1,156
+387
+50% +$16.1K ﹤0.01% 1143
2021
Q3 		$33K Hold
769
– – ﹤0.01% 1136
2021
Q2 		$31K Sell
769
-950
-55% -$36.7K ﹤0.01% 1148
2021
Q1 		$56K Buy
+1,719
New +$64.6K ﹤0.01% 986

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bessemer Group's GMAB Position: Q2 2026 in Review

Bessemer Group increased its Genmab (GMAB) stake by 1.3% in Q2 2026, buying an estimated $186 and bringing the position to 526 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

Bessemer Group first reported a position in GMAB in Q1 2021 and has held it in 18 quarters since. The position peaked at $56K in Q1 2021. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Bessemer Group held 526 shares of Genmab worth $15K as of Q2 2026.
  • Bessemer Group bought 7 Genmab shares in Q2 2026, an estimated $186.
  • Genmab made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2069 holding.
  • Bessemer Group first reported a position in Genmab in Q1 2021 and has held it in 18 quarters since.
  • Bessemer Group's Genmab position peaked at $56K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.